Carlo Riccardo Rossi1, Nicola Mozzillo2, Andrea Maurichi3, Sandro Pasquali4, Giuseppe Macripò5, Lorenzo Borgognoni6, Nicola Solari7, Dario Piazzalunga8, Luigi Mascheroni9, Giuseppe Giudice10, Simone Mocellin4, Roberto Patuzzo3, Corrado Caracò2, Simone Ribero5, Ugo Marone2, Mario Santinami3. 1. Melanoma and Sarcoma Unit, Veneto Institute of Oncology, Padova, Italy2Surgery Branch, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy. 2. Division of Melanoma-Soft Tissues-Head and Neck, Department of Surgery, National Cancer Institute "Pascale," Naples, Italy. 3. Melanoma and Sarcoma Unit, National Cancer Institute, Milan, Italy. 4. Surgery Branch, Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy. 5. Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy. 6. Plastic Surgery Unit, Regional Melanoma Referral Center, Santa Maria Annunziata Hospital, Tuscan Tumor Institute, Florence, Italy. 7. Division of Surgical Oncology, IRCC-San Martino Hospital-National Cancer Institute of Genoa, Genoa, Italy. 8. Unit of Surgery, Riuniti Hospital, Bergamo, Italy. 9. Unit of General Surgery, San Pio X Hospital, Milan, Italy. 10. Department of Plastic and Reconstructive Surgery, University of Bari, Bari, Italy.
Abstract
IMPORTANCE: Although the number of excised lymph nodes (LNs) represents a quality assurance measure in lymphadenectomy for many solid tumors, the minimum number of LNs to be dissected has not been established for melanoma. OBJECTIVE: To investigate the distribution of the number of excised LNs in a large patient series (N = 2526) to identify values that may serve as benchmarks for monitoring the quality of lymphadenectomy in patients with melanoma. DESIGN, SETTING, AND PARTICIPANTS: A retrospective multicenter study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous melanoma. Medical records on 2526 patients who underwent lymphadenectomy for regional LN metastasis associated with cutaneous melanoma were examined. EXPOSURE: Patients had undergone lymphadenectomy for regional LN metastasis. MAIN OUTCOMES AND MEASURES: The mean, median, and 10th percentile of the number of excised LNs were calculated for the axilla (3 levels), neck (≤3 or ≥4 dissected levels), inguinal, and ilioinguinal LN fields. RESULTS: After 3-level axillary (n = 1150), 3-level or less neck (n = 77), 4-level or more neck (n = 135), inguinal (n = 209), and ilioinguinal (n = 955) dissections, the median (interquartile range [IQR]) and mean (SD) number of excised LNs were as follows: 3-level axillary dissection, 20 (15-27) and 22 (8); 3-level or less neck, 21 (14-33) and 24 (15); 4-level or more neck, 29 (21-41) and 31 (14); inguinal, 11 ( 9-14) and 12 (5); and ilioinguinal, 21 (16-26) and 22 (4). A total of 90% of the patients had 12, 7, 14, 6, and 13 excised LNs (10th percentile of the distribution) after 3-level axillary, 3-level or less neck, 4-level or more neck, inguinal, and ilioinguinal dissections, respectively. More excised LNs were detected in younger (21 for those <54 years of age and 19 for ≥54 years, P < .001) and male (21 for male sex and 19 for female sex, P < .001) patients from high-volume institutions (21 for volume of ≥300 vs 18 for volume <300, P < .001) with a more recent year of diagnosis (21 for years 2002-2010 vs 18 for years 1992-2001, P < .001), LN micrometastasis vs macrometastasis (20 vs 19, P = .005), and more positive LNs (R² = 0.03, P < .001); however, the differences between median values were small. CONCLUSIONS AND RELEVANCE: These minimum numbers of excised LNs are reproducible across the institution, patient, and tumor factors evaluated. They can be taken into consideration when monitoring the quality of lymphadenectomy in melanoma and can represent entry criteria for randomized trials investigating adjuvant therapies.
IMPORTANCE: Although the number of excised lymph nodes (LNs) represents a quality assurance measure in lymphadenectomy for many solid tumors, the minimum number of LNs to be dissected has not been established for melanoma. OBJECTIVE: To investigate the distribution of the number of excised LNs in a large patient series (N = 2526) to identify values that may serve as benchmarks for monitoring the quality of lymphadenectomy in patients with melanoma. DESIGN, SETTING, AND PARTICIPANTS: A retrospective multicenter study was conducted (1992-2010) in tertiary referral centers for treatment of cutaneous melanoma. Medical records on 2526 patients who underwent lymphadenectomy for regional LN metastasis associated with cutaneous melanoma were examined. EXPOSURE: Patients had undergone lymphadenectomy for regional LN metastasis. MAIN OUTCOMES AND MEASURES: The mean, median, and 10th percentile of the number of excised LNs were calculated for the axilla (3 levels), neck (≤3 or ≥4 dissected levels), inguinal, and ilioinguinal LN fields. RESULTS: After 3-level axillary (n = 1150), 3-level or less neck (n = 77), 4-level or more neck (n = 135), inguinal (n = 209), and ilioinguinal (n = 955) dissections, the median (interquartile range [IQR]) and mean (SD) number of excised LNs were as follows: 3-level axillary dissection, 20 (15-27) and 22 (8); 3-level or less neck, 21 (14-33) and 24 (15); 4-level or more neck, 29 (21-41) and 31 (14); inguinal, 11 ( 9-14) and 12 (5); and ilioinguinal, 21 (16-26) and 22 (4). A total of 90% of the patients had 12, 7, 14, 6, and 13 excised LNs (10th percentile of the distribution) after 3-level axillary, 3-level or less neck, 4-level or more neck, inguinal, and ilioinguinal dissections, respectively. More excised LNs were detected in younger (21 for those <54 years of age and 19 for ≥54 years, P < .001) and male (21 for male sex and 19 for female sex, P < .001) patients from high-volume institutions (21 for volume of ≥300 vs 18 for volume <300, P < .001) with a more recent year of diagnosis (21 for years 2002-2010 vs 18 for years 1992-2001, P < .001), LN micrometastasis vs macrometastasis (20 vs 19, P = .005), and more positive LNs (R² = 0.03, P < .001); however, the differences between median values were small. CONCLUSIONS AND RELEVANCE: These minimum numbers of excised LNs are reproducible across the institution, patient, and tumor factors evaluated. They can be taken into consideration when monitoring the quality of lymphadenectomy in melanoma and can represent entry criteria for randomized trials investigating adjuvant therapies.
Authors: Enrique Boldo; Araceli Mayol; Rafael Lozoya; Alba Coret; Diana Escribano; Carlos Fortea; Andres Muñoz; Juan Carlos Pastor; Guillermo Perez De Lucia Journal: Melanoma Manag Date: 2020-07-21
Authors: D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero Journal: Br J Cancer Date: 2017-11-09 Impact factor: 7.640
Authors: Antonella Vecchiato; Simone Mocellin; Paolo Del Fiore; Giulio Tosti; Paolo A Ascierto; Maria Teresa Corradin; Vincenzo De Giorgi; Giuseppe Giudice; Paola Queirolo; Caterina Ferreli; Marcella Occelli; Monica Giordano; Giusto Trevisan; Luigi Mascheroni; Alessandro Testori; Romina Spina; Alessandra Buja; Francesco Cavallin; Corrado Caracò; Antonio Sommariva; Carlo Riccardo Rossi Journal: BMC Cancer Date: 2021-01-05 Impact factor: 4.430
Authors: Paolo A Ascierto; Michael Atkins; Carlo Bifulco; Gerardo Botti; Alistair Cochran; Michael Davies; Sandra Demaria; Reinhard Dummer; Soldano Ferrone; Silvia Formenti; Thomas F Gajewski; Claus Garbe; Samir Khleif; Rolf Kiessling; Roger Lo; Paul Lorigan; Grant Mc Arthur; Giuseppe Masucci; Ignacio Melero; Martin Mihm; Giuseppe Palmieri; Giorgio Parmiani; Igor Puzanov; Pedro Romero; Bastian Schilling; Barbara Seliger; David Stroncek; Janis Taube; Sara Tomei; Hassane M Zarour; Alessandro Testori; Ena Wang; Jérôme Galon; Gennaro Ciliberto; Nicola Mozzillo; Francesco M Marincola; Magdalena Thurin Journal: J Transl Med Date: 2015-11-30 Impact factor: 5.531